Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
新辅助乳腺癌的化疗反应和无复发生存期取决于生物标志物谱:I-SPY 1 试验的结果(CALGB 150007/150012;ACRIN 6657)
期刊:Breast Cancer Res Treat
影响因子:3.000
doi:10.1007/s10549-011-1895-2.
Laura J Esserman ,Donald A Berry, Maggie C U Cheang, Christina Yau, Charles M Perou, Lisa Carey, Angela DeMichele, Joe W Gray, Kathleen Conway-Dorsey, Marc E Lenburg, Meredith B Buxton, Sarah E Davis, Laura J van't Veer, Clifford Hudis, Koei Chin, Denise Wolf, Helen Krontiras, Leslie Montgomery, Debu Tripathy, Constance Lehman, Minetta C Liu, Olufunmilayo I Olopade, Hope S Rugo, John T Carpenter, Chad Livasy, Lynn Dressler, David Chhieng, Baljit Singh, Carolyn Mies, Joseph Rabban, Yunni-Yi Chen, Dilip Giri, Alfred Au, Nola Hylton; I-SPY 1 TRIAL Investigators